Dermata Therapeutics, Inc. - Common Stock (DRMA)

Dermata Therapeutics Inc is a biotechnology company focused on developing innovative therapeutics for skin diseases and conditions

The company leverages its proprietary technology platform to create treatments that aim to improve patient outcomes in dermatology. Dermata Therapeutics is committed to addressing unmet medical needs and advancing its product candidates through various stages of clinical development. By prioritizing research and development, the company seeks to bring forward effective solutions for skin health and enhance the quality of life for individuals affected by dermatological disorders.